Antibe Announces FDA Clinical Hold on Otenaproxesul and Legal Action by Nuance
Contacts Antibe Therapeutics Inc. Christina Cameron VP Investor Relations +1 416-577-1443 christina@antibethera.com Antibe Therapeutics Inc. (“Antibe” or the “Company” TSX:...